$CBDY
Target Group Inc.

2024 Q2 Form 10-Q Financial Statement

#000141057824000628 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $2.275M $1.920M
YoY Change 199.74%
Cost Of Revenue $806.2K $1.110M
YoY Change 118.32%
Gross Profit $1.469M $810.2K
YoY Change 276.89%
Gross Profit Margin 64.56% 42.2%
Selling, General & Admin $343.2K $388.5K
YoY Change 34.6% 185.12%
% of Gross Profit 23.37% 47.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $203.7K $236.0K
YoY Change -11.27% 10.95%
% of Gross Profit 13.87% 29.13%
Operating Expenses $567.7K $699.0K
YoY Change 13.43% 105.16%
Operating Profit $901.2K $111.2K
YoY Change -913.87%
Interest Expense -$271.1K $349.3K
YoY Change -173.44% -1.21%
% of Operating Profit -30.08% 314.27%
Other Income/Expense, Net -$234.5K -$304.3K
YoY Change -121.82% -24.86%
Pretax Income $666.7K -$193.2K
YoY Change -30.83% -74.1%
Income Tax
% Of Pretax Income
Net Earnings $666.7K -$193.2K
YoY Change -30.83% -74.1%
Net Earnings / Revenue 29.3% -10.06%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 617.0M 617.0M
Diluted Shares Outstanding 617.0M 617.0M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.734M $745.6K
YoY Change 65.46% 1411.11%
Cash & Equivalents $1.742M $754.1K
Short-Term Investments
Other Short-Term Assets $49.68K $50.19K
YoY Change -3.27% -92.68%
Inventory $527.6K $738.1K
Prepaid Expenses $41.28K $41.70K
Receivables $472.8K $88.70K
Other Receivables $38.74K $70.70K
Total Short-Term Assets $2.823M $1.693M
YoY Change -3.37% 124.16%
LONG-TERM ASSETS
Property, Plant & Equipment $4.811M $5.068M
YoY Change -16.67% -5.21%
Goodwill $260.4K $263.0K
YoY Change -3.27% -0.12%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.115M $5.377M
YoY Change -16.11% -22.5%
TOTAL ASSETS
Total Short-Term Assets $2.823M $1.693M
Total Long-Term Assets $5.115M $5.377M
Total Assets $7.938M $7.071M
YoY Change -11.98% -8.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.712M $428.0K
YoY Change 434.91% -94.36%
Accrued Expenses $134.8K $2.067M
YoY Change -94.46% 1730.05%
Deferred Revenue
YoY Change
Short-Term Debt $990.00 $990.00
YoY Change 0.0% 0.0%
Long-Term Debt Due $7.615M $7.692M
YoY Change 394.43% 371.37%
Total Short-Term Liabilities $13.22M $12.98M
YoY Change 64.86% 68.44%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.112M $1.160M
YoY Change -13.75% -10.18%
Total Long-Term Liabilities $1.112M $1.160M
YoY Change -85.3% -84.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.22M $12.98M
Total Long-Term Liabilities $1.112M $1.160M
Total Liabilities $14.33M $14.14M
YoY Change -8.03% -5.72%
SHAREHOLDERS EQUITY
Retained Earnings -$30.63M -$31.30M
YoY Change 0.22% -0.73%
Common Stock $61.70K $61.70K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.397M -$7.073M
YoY Change
Total Liabilities & Shareholders Equity $7.938M $7.071M
YoY Change -11.98% -8.1%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $666.7K -$193.2K
YoY Change -30.83% -74.1%
Depreciation, Depletion And Amortization $203.7K $236.0K
YoY Change -11.27% 10.95%
Cash From Operating Activities $981.1K $774.4K
YoY Change -903.69% -514.68%
INVESTING ACTIVITIES
Capital Expenditures $20.43K $2.520K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $36.81K
YoY Change -96.26%
Cash From Investing Activities $16.38K -$2.517K
YoY Change -98.34% -99.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.350K -741.5K
YoY Change -95.28% -233.71%
NET CHANGE
Cash From Operating Activities 981.1K 774.4K
Cash From Investing Activities 16.38K -2.517K
Cash From Financing Activities 5.350K -741.5K
Net Change In Cash 1.003M 30.43K
YoY Change 2.79% -117.78%
FREE CASH FLOW
Cash From Operating Activities $981.1K $774.4K
Capital Expenditures $20.43K $2.520K
Free Cash Flow $960.6K $771.9K
YoY Change -513.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q4 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024Q1 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001586554
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Trading Symbol
TradingSymbol
CBDY
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
617025999
CY2024Q1 us-gaap Other Receivable After Allowance For Credit Loss Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024Q1 us-gaap Accounts Payable Current Related Party Type Extensible Enumeration
AccountsPayableCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Interest Expense Operating Related Party Type Extensible Enumeration
InterestExpenseOperatingRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2024Q1 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024Q1 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-55066
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
TARGET GROUP INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3621499
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
20 Hempstead Drive
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Hamilton
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Ontario
CY2024Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L8W 2E7
CY2024Q1 dei City Area Code
CityAreaCode
1 905
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
541-3833
CY2024Q1 dei Security12g Title
Security12gTitle
Common Stock, Par Value $0.0001
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
617025999
CY2024Q1 us-gaap Cash
Cash
745582
CY2023Q4 us-gaap Cash
Cash
736323
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
8488
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
8696
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88699
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1031530
CY2024Q1 us-gaap Inventory Net
InventoryNet
738115
CY2023Q4 us-gaap Inventory Net
InventoryNet
1215928
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41697
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
42720
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
55268
CY2024Q1 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
67013
CY2024Q1 us-gaap Other Receivables
OtherReceivables
3690
CY2023Q4 us-gaap Other Receivables
OtherReceivables
3781
CY2024Q1 us-gaap Assets Current
AssetsCurrent
1693284
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3094246
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5067919
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5430260
CY2024Q1 us-gaap Goodwill
Goodwill
263010
CY2023Q4 us-gaap Goodwill
Goodwill
269460
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46521
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46936
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
5377450
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
5746656
CY2024Q1 us-gaap Assets
Assets
7070734
CY2023Q4 us-gaap Assets
Assets
8840902
CY2024Q1 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
506
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2364625
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2945568
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
42066
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43098
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
48581
CY2024Q1 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
10437340
CY2023Q4 cbdy Related Party Payables Net Current
RelatedPartyPayablesNetCurrent
11415557
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
130187
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
127478
CY2024Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
480
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7931
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8021
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12983135
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14589289
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1159541
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1223955
CY2024Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
696
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
355
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1160237
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1224310
CY2024Q1 us-gaap Liabilities
Liabilities
14143372
CY2023Q4 us-gaap Liabilities
Liabilities
15813599
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
100
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
61703
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
61703
CY2024Q1 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175439
CY2023Q4 cbdy Shares To Be Issued Total
SharesToBeIssuedTotal
175439
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24985697
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31300516
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31107348
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-995061
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1088288
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-7072638
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6972697
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7070734
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8840902
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1919931
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1109764
CY2024Q1 us-gaap Gross Profit
GrossProfit
810167
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
74543
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
223
CY2024Q1 us-gaap Management Fee Expense
ManagementFeeExpense
97361
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
78324
CY2024Q1 us-gaap Legal Fees
LegalFees
77659
CY2023Q1 us-gaap Legal Fees
LegalFees
57940
CY2024Q1 us-gaap Depreciation
Depreciation
235971
CY2023Q1 us-gaap Depreciation
Depreciation
212686
CY2024Q1 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
-54472
CY2023Q1 cbdy Operating Lease Income Expense
OperatingLeaseIncomeExpense
11090
CY2024Q1 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-151592
CY2023Q1 cbdy General And Administrative Income Expense
GeneralAndAdministrativeIncomeExpense
-2629
CY2024Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
7415
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
699013
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
340712
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-252
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2975
CY2024Q1 us-gaap Interest Expense
InterestExpense
349326
CY2023Q1 us-gaap Interest Expense
InterestExpense
353606
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
49231
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2275
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4275
CY2024Q1 cbdy Allowance Recovery For Sales Tax Recoverable
AllowanceRecoveryForSalesTaxRecoverable
8464
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-43963
CY2024Q1 cbdy Debt Issuance Costs
DebtIssuanceCosts
12439
CY2023Q1 cbdy Debt Issuance Costs
DebtIssuanceCosts
12403
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-304322
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-404997
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-193168
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-745709
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-193168
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-745709
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
93227
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2019
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-99941
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-747728
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0003
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0003
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0012
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0012
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
617025999
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
617025999
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6972697
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-193168
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
93227
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-7072638
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6559825
CY2023Q1 cbdy Shares To Be Issued As Compensation To Intellectual Property Rights Value
SharesToBeIssuedAsCompensationToIntellectualPropertyRightsValue
63
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-745709
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2019
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-7307490
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-193168
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-745709
CY2024Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-252
CY2023Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2975
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
223
CY2024Q1 cbdy Allowance For Sales Tax Recoverable
AllowanceForSalesTaxRecoverable
8464
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
235971
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
212686
CY2024Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
50814
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
60053
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-43963
CY2024Q1 cbdy Debt Issuance Costs
DebtIssuanceCosts
12439
CY2023Q1 cbdy Debt Issuance Costs
DebtIssuanceCosts
12403
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-922542
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-54201
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-450833
CY2024Q1 cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-106508
CY2023Q1 cbdy Increase Decrease In Sales Tax Recoverable
IncreaseDecreaseInSalesTaxRecoverable
-50405
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-563445
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
362991
CY2024Q1 cbdy Change In Operating Lease Liability Net
ChangeInOperatingLeaseLiabilityNet
81019
CY2023Q1 cbdy Change In Operating Lease Liability Net
ChangeInOperatingLeaseLiabilityNet
79990
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
774448
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-186760
CY2024Q1 cbdy Payments For Proceeds From Property Plant And Equipment
PaymentsForProceedsFromPropertyPlantAndEquipment
2517
CY2023Q1 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
538911
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2517
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-538911
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
554550
CY2024Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
741500
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-741500
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
554550
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
30431
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-171121
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-21380
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-3379
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
745019
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232333
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
754070
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57833
CY2024Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
63
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
280
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
947901
CY2024Q1 us-gaap Area Of Land
AreaOfLand
44000
CY2024Q1 cbdy Settlement Liabilities Current And Noncurrent
SettlementLiabilitiesCurrentAndNoncurrent
0
CY2024Q1 cbdy Working Capital Deficit
WorkingCapitalDeficit
11289851
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31300516
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The preparation of the unaudited condensed consolidated interim financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated interim financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates may include those pertaining to accruals. Actual results could differ from those estimates.</span></p>
CY2024Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
18294
CY2024Q1 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
664200
CY2024Q1 cbdy Accrued Interest Converted Into Principal
AccruedInterestConvertedIntoPrincipal
900000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1919931
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2023Q1 cbdy Revenue From Investments In Joint Venture
RevenueFromInvestmentsInJointVenture
200641
CY2024Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
53595
CY2024Q1 us-gaap Inventory Net
InventoryNet
738115
CY2023Q1 us-gaap Inventory Net
InventoryNet
1215928
CY2023Q1 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
144437
CY2023Q1 cbdy Recoverable Expenses From Jv Co Related To Rent And Utilities
RecoverableExpensesFromJvCoRelatedToRentAndUtilities
217363
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
468034
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
270081
CY2024Q1 us-gaap Inventory Net
InventoryNet
738115
CY2024Q1 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
8424
CY2023Q4 cbdy Allowance On Value Added Tax Recoverable
AllowanceOnValueAddedTaxRecoverable
0
CY2017Q3 us-gaap Area Of Land
AreaOfLand
44000
CY2019Q2 us-gaap Area Of Land
AreaOfLand
44000
CY2024Q1 cbdy Depreciation Of Joint Venture Consolidated
DepreciationOfJointVentureConsolidated
23038
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8956039
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3888120
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5067919
CY2024Q1 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
54472
CY2023Q1 cbdy Operating Lease Expenses Total
OperatingLeaseExpensesTotal
-11090
CY2024Q1 cbdy Equity Method Investments Joint Venture
EquityMethodInvestmentsJointVenture
1023608
CY2024Q1 cbdy Receivables From Joint Venture
ReceivablesFromJointVenture
698645
CY2024Q1 cbdy Payable To Joint Venture
PayableToJointVenture
-129185
CY2024Q1 cbdy Gross Investment In Joint Venture
GrossInvestmentInJointVenture
1593068
CY2024Q1 us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
776382
CY2024Q1 cbdy Net Amount Of Investment In Joint Venture
NetAmountOfInvestmentInJointVenture
816686
CY2024Q1 cbdy Asset Acquired Fair Value Of Accounts Receivables Joint Venture
AssetAcquiredFairValueOfAccountsReceivablesJointVenture
163244
CY2024Q1 cbdy Asset Acquired Fair Value Of Inventory Joint Venture
AssetAcquiredFairValueOfInventoryJointVenture
1690368
CY2024Q1 cbdy Asset Acquired Fair Value Of Fixed Assets Joint Venture
AssetAcquiredFairValueOfFixedAssetsJointVenture
534816
CY2024Q1 cbdy Asset Acquired Fair Value Joint Venture
AssetAcquiredFairValueJointVenture
2388428
CY2024Q1 cbdy Gain Loss Net On Consolidation Of Joint Venture
GainLossNetOnConsolidationOfJointVenture
1571742
CY2023Q2 cbdy Equity Method Investments Joint Venture
EquityMethodInvestmentsJointVenture
1023608
CY2023Q2 cbdy Receivables From Joint Venture
ReceivablesFromJointVenture
706598
CY2023Q2 cbdy Proceeds From Joint Venture
ProceedsFromJointVenture
776382
CY2023Q2 cbdy Investment In Joint Venture Balance
InvestmentInJointVentureBalance
953824
CY2023Q2 cbdy Gain From Termination Of Joint Venture
GainFromTerminationOfJointVenture
1571742
CY2018Q2 cbdy Business Acquisition Equity Interest Issuable Percentage
BusinessAcquisitionEquityInterestIssuablePercentage
0.4627
CY2024Q1 cbdy Class Of Warrant Or Right Warrants Exercised During Period
ClassOfWarrantOrRightWarrantsExercisedDuringPeriod
0
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
2989283
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4702543
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
7691826
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
7691826
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
67812
CY2024Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
49518
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
9
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
10
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2886380
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2130149
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
2786380
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
2056349
CY2024Q1 us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
250387
CY2024Q1 us-gaap Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
337449
CY2024Q1 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
249038
CY2024Q1 cbdy Line Of Credit Facility Accrued Interest
LineOfCreditFacilityAccruedInterest
337449
CY2023Q1 cbdy Advance Paid To Related Party
AdvancePaidToRelatedParty
500000.00
CY2023Q1 cbdy Lender Fees
LenderFees
50000
CY2024Q1 cbdy Number Of Operating Lease Facilities
NumberOfOperatingLeaseFacilities
2
CY2024Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.16
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
241909
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
325771
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
329029
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
332319
CY2024Q1 cbdy Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
788771
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2017799
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
728071
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1289728
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
130187
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1159541
CY2024Q1 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
50814
CY2023Q1 cbdy Gross Operating Lease Expense
GrossOperatingLeaseExpense
61836
CY2024Q1 cbdy Gross Operating Leases Rent And Utilities Expenses
GrossOperatingLeasesRentAndUtilitiesExpenses
3658
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8021
CY2024Q1 cbdy Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-90
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7931
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
617025999
CY2024Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
100
CY2024Q1 cbdy Schedule Of Shares To Be Issued
ScheduleOfSharesToBeIssued
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:25.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:50.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:25.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Disclosure for shares to be issued :</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:50.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:25.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amount</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:50.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:25.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:50.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">80,000 shares of common stock to be issued as compensation to advisers and consultants. These were recorded at fair value of $52,000, based on the market price of the Company’s stock on the date of issue.</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:25.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Services</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.19%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 73,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:50.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">35,000 to be issued as settlement of the amount due for website development services amounting to $247,306. The fair value of the shares on the date of settlement was $21,000, resulting in a gain on settlement amounting to $226,306 during the year ended December 31, 2017.</p></td></tr><tr><td style="vertical-align:bottom;width:25.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Private placements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 346,296</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18,787</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:50.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Consideration for private placements with the fair value based on cash proceeds received. Proper allocation between common stock and additional paid-in capital of the amount received will be completed in the period when the shares are issued.</p></td></tr><tr><td style="vertical-align:bottom;width:25.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Settlement of loans of CannaKorp</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 930,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,838</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:50.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Refer to Note 9 for details.</p></td></tr><tr><td style="vertical-align:bottom;width:25.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">Agreement with Serious Seeds</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 249,984</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.19%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,814</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;width:50.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">As consideration for intellectual property rights granted by Smit. The fair value is based on the market price of the Company’s stock on the date of issue as per the agreement.</p></td></tr><tr><td style="vertical-align:bottom;width:25.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.17%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,641,520</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.19%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 175,439</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:50.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr></table>
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
115000
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73000
CY2024Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.33
CY2024Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
134
CY2023Q4 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q3 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q2 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q1 cbdy Share Based Compensation Share Based Payments Forfeiture Rate
ShareBasedCompensationShareBasedPaymentsForfeitureRate
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.350
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.300
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
4.38
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.99
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.42
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
3.05
CY2023Q4 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q3 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q2 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q1 cbdy Fair Value Assumptions Term
FairValueAssumptionsTerm
P2Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q4 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
158
CY2023Q3 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
313
CY2023Q2 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
138
CY2023Q1 cbdy Business Acquisition Fair Value Of Equity Interest Issued Or Issuable
BusinessAcquisitionFairValueOfEquityInterestIssuedOrIssuable
160
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10400008
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10400008
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
354
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
135
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
207
CY2024Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
696
CY2024Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1374750
CY2024Q1 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
1862805
CY2024Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
10843
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-24-000628-index-headers.html Edgar Link pending
0001410578-24-000628-index.html Edgar Link pending
0001410578-24-000628.txt Edgar Link pending
0001410578-24-000628-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20240331.xsd Edgar Link pending
tmb-20240331x10q.htm Edgar Link pending
tmb-20240331xex31d1.htm Edgar Link pending
tmb-20240331xex31d2.htm Edgar Link pending
tmb-20240331xex32d1.htm Edgar Link pending
tmb-20240331_cal.xml Edgar Link unprocessable
tmb-20240331_def.xml Edgar Link unprocessable
tmb-20240331_pre.xml Edgar Link unprocessable
tmb-20240331_lab.xml Edgar Link unprocessable
tmb-20240331x10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable